<DOC>
	<DOC>NCT00854971</DOC>
	<brief_summary>The purpose of this study is to determine efficacy of NKCell in colorectal cancer</brief_summary>
	<brief_title>Efficacy Study of TKcell in Advanced Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Written informed consent. Diagnosis of histologically confirmed adenocarcinoma of the colorectal ECOG performance status of 0 2 At least one definite measurable lesion(s): ≥ 1 cm on spiral CT scan or ≥2cm in physical examination Adequate liver, renal, bone marrow functions as evidence by the following; Absolute neutrophil count &gt; 1.5 x 109/L; platelets &gt; 7.5 x 109/L; Bilirubin less than 2 mg/dL ASAT and/or ALAT &lt; 5 UNL; serum creatinine ≤ 2 ULN Minimum life expectancy of 12 weeks Effective contraception for both male and female subjects if the risk of conception exists Brain metastasis and/or leptomeningeal disease (known or suspected) Previous chemotherapy for gastric cancer except adjuvant treatment with progression of disease documented &gt; 6 months after end of adjuvant treatment. Previous oxaliplatinbased chemotherapy Surgery (excluding diagnostic biopsy) or irradiation within 4 weeks prior to randomization and chemotherapy HIV antibody (+), Chronic hepatitis Uncontrolled infection Concurrent or previous chronic systemic immune therapy, targeted therapy, hormonal therapy not indicated in the study protocol except for contraception Clinically relevant coronary artery disease, history of myocardial infarction, high risk of uncontrolled arrhythmia Known hypersensitivity reaction to any of the components of the treatment. Pregnancy (absence to be confirmed by ßhCG test) or lactation period Participation in another clinical study within the 30 days before randomization Significant disease which, in the investigator's opinion, would exclude the subject from the study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>NKCell</keyword>
	<keyword>FOLFOX-4</keyword>
	<keyword>advanced or unresectable colorectal cancer</keyword>
</DOC>